Postdoctoral Position in Cell Cycle and Cancer Research, University of Santiago

Spain - University of Santiago, Postdoctoral position in Cell Cycle and Cancer Research

Postdoctoral positions are available to join the Cell Cycle and Oncology Group at Universidade de Santiago de Compostela.

We are looking for highly motivated people, with a Ph.D. in life sciences and a background in Molecular Biology, Genetics or Biochemistry. Experience in the generation and/or analysis of genetically modified mice is a plus. International publications are required.

Current research interests:

• Cdk inhibitors in tumor suppression: functions on and beyond cell cycle.
• Functional genomics in tumor marker discovery and validation.
• Genetically modified mice as preclinical models in new anti-cancer therapeutic approaches.

The Cell Cycle and Oncology group was established in 2003. Since then the lab have generated several high-impact papers and is funded by public and private agencies. The group is currently composed by 7 PhD students and 2 technicians.

Publications (2004-2008):
Vidal A et al. p130 and p27 co-operate to control mobilization of angiogenic progenitors from the bone marrow. Proc. Natl. Acad. Sci. USA, 102: 6890-6895. (2005)
Canibano C et al. The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. EMBO J. 26: 2015- 2028 (2007)
Vidal A et al. Of mice without pockets: mouse models to study the function of Rb family proteins. Front Biosci 12: 4483- 4496 (2007)
Yeh N et al. Cooperation between p27 and p107 during endochondral ossification suggests a genetic pathway controlled by p27 and p130. Mol Cell Biol 27: 5161-5171.(2007)
Pazos Chantrero E et al. Cyclin A probes by means of intermolecular sensitization of terbium-chelating peptides. J Am Chem Soc, 130(30):9652-9653 (2008)
Castro-Feijóo L et al. Hypochondroplasia and acanthosis nigricans: a new syndrome due to the p.Lys650Thr mutation in the FGFR3 gene? Eur. J. Endocrinol. 159: 243-249 (2008)
Lozano MV et al. A highly efficient system to delivery taxanes into tumor cells: Docetaxel-loaded chitosan oligomer nanocapsules. Biomacromolecules, 9: 2186-93 (2008)

Review of applications will begin immediately and will continue until a suitable candidate is found.

To apply:
Interested candidates please send CV and a letter of research interests to Anxo Vidal at anxo.vidal@usc.es.
http://www.usc.es/